Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer
Author:
Publisher
Elsevier BV
Subject
Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine
Reference66 articles.
1. The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non-small cell lung cancer;Bremnes;J. Thorac. Oncol.,2016
2. Omic techniques in systems biology approaches to traditional Chinese medicine research: present and future;Buriani;J. Ethnopharmacol.,2012
3. Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC;Camidge;Nat. Rev. Clin. Oncol.,2019
4. CACNA1C is a prognostic predictor for patients with ovarian cancer;Chang;J Ovarian Res,2021
5. The IASLC lung cancer staging project: external validation of the revision of the tnm stage groupings in the eighth edition of the TNM classification of lung cancer;Chansky;J. Thorac. Oncol.,2017
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Application of omics technologies in studies on antitumor effects of Traditional Chinese Medicine;Chinese Medicine;2024-09-09
2. The mechanism of Xihuang pills' intervention in the tumour immune microenvironment for the treatment of liver cancer based on the STAT3-PDL1 pathway;Journal of Ethnopharmacology;2024-09
3. Anoikis-related CTNND1 is associated with immuno-suppressive tumor microenvironment and predicts unfavorable immunotherapeutic outcome in non-small cell lung cancer;Journal of Cancer;2024
4. Xihuang pill ameliorates colitis in mice by improving mucosal barrier injury and inhibiting inflammatory cell filtration through network regulation;Journal of Ethnopharmacology;2024-01
5. Drug monomers from Salvia miltiorrhiza Bge. promoting tight junction protein expression for therapeutic effects on lung cancer;Scientific Reports;2023-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3